CM HOSPITALAR S/A |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.4 BRL | -2.83% |
|
-8.75% | -82.80% |
| 10/05 | CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 26/03 | CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,399 | 4,570 | 4,465 | 764.4 | - | - |
| Enterprise Value (EV) 1 | 5,472 | 5,887 | 7,410 | 3,684 | 3,622 | 3,774 |
| P/E ratio | 12.5 x | 17.6 x | 11.6 x | -327 x | 5.32 x | 3.41 x |
| Yield | 2.14% | 1.72% | - | 1.15% | 8.73% | 9.11% |
| Capitalization / Revenue | 0.87 x | 0.52 x | 0.4 x | 0.06 x | 0.06 x | 0.05 x |
| EV / Revenue | 0.88 x | 0.67 x | 0.67 x | 0.31 x | 0.28 x | 0.27 x |
| EV / EBITDA | 11.6 x | 8.05 x | 7.99 x | 5.48 x | 3.82 x | 3.65 x |
| EV / FCF | 40.1 x | -5.56 x | -5.1 x | 4.36 x | 10.3 x | 11.4 x |
| FCF Yield | 2.5% | -18% | -19.6% | 22.9% | 9.73% | 8.8% |
| Price to Book | 2.51 x | 2 x | 1.36 x | 0.23 x | 0.23 x | 0.23 x |
| Nbr of stocks (in thousands) | 2,86,123 | 2,83,350 | 3,20,047 | 3,18,494 | - | - |
| Reference price 2 | 18.87 | 16.13 | 13.95 | 2.400 | 2.400 | 2.400 |
| Announcement Date | 10/03/22 | 09/03/23 | 25/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 6,219 | 8,747 | 11,084 | 11,856 | 12,955 | 14,127 |
| EBITDA 1 | - | 471.4 | 731.4 | 927.5 | 672 | 948.3 | 1,034 |
| EBIT 1 | - | 373.2 | 555 | 666.9 | 429.3 | 666.5 | 694.9 |
| Operating Margin | - | 6% | 6.35% | 6.02% | 3.62% | 5.14% | 4.92% |
| Earnings before Tax (EBT) 1 | - | 408.9 | 208.1 | 138.5 | -64.75 | 250.1 | 268.5 |
| Net income 1 | 121.8 | 395.2 | 259.7 | 359.9 | 5.898 | 216.7 | 226.3 |
| Net margin | - | 6.35% | 2.97% | 3.25% | 0.05% | 1.67% | 1.6% |
| EPS 2 | 0.5436 | 1.510 | 0.9154 | 1.200 | -0.007340 | 0.4510 | 0.7047 |
| Free Cash Flow 1 | - | 136.6 | -1,059 | -1,452 | 844.5 | 352.3 | 332 |
| FCF margin | - | 2.2% | -12.11% | -13.1% | 7.12% | 2.72% | 2.35% |
| FCF Conversion (EBITDA) | - | 28.98% | - | - | 125.68% | 37.15% | 32.12% |
| FCF Conversion (Net income) | - | 34.57% | - | - | 14,318.24% | 162.59% | 146.69% |
| Dividend per Share 2 | - | 0.4046 | 0.2769 | - | 0.0275 | 0.2094 | 0.2187 |
| Announcement Date | 18/03/21 | 10/03/22 | 09/03/23 | 25/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,621 | 1,900 | 1,946 | 2,274 | 2,627 | 2,800 | 2,534 | 2,845 | 2,905 | 2,958 | 2,813 | 3,056 | 3,145 | 3,271 | - |
| EBITDA 1 | 128.9 | 167.3 | 176.1 | 188.7 | 199.3 | 223.2 | 251.1 | 250.8 | 202.5 | 151.6 | 173.2 | 200.4 | 206.2 | - | - |
| EBIT 1 | 104.2 | - | 138.8 | 144.3 | 145.2 | 162.1 | 185.3 | 167.6 | 135.6 | 77.93 | 78.65 | 125.6 | 129.1 | - | - |
| Operating Margin | 6.43% | - | 7.13% | 6.34% | 5.53% | 5.79% | 7.31% | 5.89% | 4.67% | 2.63% | 2.8% | 4.11% | 4.1% | - | - |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | - | - | 30.34 | -43.01 | -34.22 | 6.47 | 8.238 | - | - |
| Net income | 81.62 | 97 | - | - | 63.18 | 36.89 | 55.47 | 6.315 | 261.2 | 3.043 | - | - | - | - | - |
| Net margin | 5.03% | 5.11% | - | - | 2.41% | 1.32% | 2.19% | 0.22% | 8.99% | 0.1% | - | - | - | - | - |
| EPS 2 | 0.2800 | - | 0.1612 | 0.1901 | 0.2235 | 0.1302 | 0.1958 | 0.0206 | 0.8530 | 0.009530 | -0.1225 | -0.0491 | 0.0808 | 0.0600 | 0.0700 |
| Dividend per Share 2 | 0.4046 | - | - | - | 0.2769 | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/03/22 | 09/05/22 | 09/08/22 | 10/11/22 | 09/03/23 | 11/05/23 | 14/08/23 | 13/11/23 | 25/03/24 | 09/05/24 | - | - | - | - | - |
1BRL in Million2BRL
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 72.5 | 1,316 | 2,946 | 2,920 | 2,858 | 3,009 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 0.1538 x | 1.8 x | 3.176 x | 4.345 x | 3.014 x | 2.911 x |
| Free Cash Flow 1 | - | 137 | -1,059 | -1,452 | 845 | 352 | 332 |
| ROE (net income / shareholders' equity) | - | 23.6% | 11.7% | 12.9% | 0.86% | 4.39% | 6.48% |
| ROA (Net income/ Total Assets) | - | - | 3.16% | 3.65% | 0.01% | 0.84% | 1.5% |
| Assets 1 | - | - | 8,229 | 9,873 | 53,619 | 25,676 | 15,119 |
| Book Value Per Share 2 | - | 7.520 | 8.050 | 10.30 | 10.30 | 10.50 | 10.50 |
| Cash Flow per Share | - | 0.8200 | - | -2.980 | - | - | - |
| Capex 1 | - | 78 | 1,592 | 556 | 165 | 239 | 268 |
| Capex / Sales | - | 1.25% | 18.2% | 5.02% | 1.39% | 1.84% | 1.89% |
| Announcement Date | 18/03/21 | 10/03/22 | 09/03/23 | 25/03/24 | - | - | - |
1BRL in Million2BRL
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
2.4
BRL
Average target price
7.725
BRL
Spread / Average Target
+221.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -82.80% | 140M | |
| +25.72% | 75.5B | |
| -4.79% | 23.38B | |
| +17.81% | 8.96B | |
| -31.67% | 6.83B | |
| +21.79% | 5.59B | |
| +4.12% | 4.26B | |
| -3.94% | 4B | |
| +13.98% | 3.49B | |
| +10.59% | 3.29B |
- Stock Market
- Equities
- VVEO3 Stock
- Financials CM Hospitalar S/A
